174 related articles for article (PubMed ID: 33478114)
1. Assessment of the Telomere Length and Its Effect on the Symptomatology of Parkinson's Disease.
Levstek T; Redenšek S; Trošt M; Dolžan V; Podkrajšek KT
Antioxidants (Basel); 2021 Jan; 10(1):. PubMed ID: 33478114
[TBL] [Abstract][Full Text] [Related]
2. Study of telomere length and different markers of oxidative stress in patients with Parkinson's disease.
Watfa G; Dragonas C; Brosche T; Dittrich R; Sieber CC; Alecu C; Benetos A; Nzietchueng R
J Nutr Health Aging; 2011 Apr; 15(4):277-81. PubMed ID: 21437559
[TBL] [Abstract][Full Text] [Related]
3. Telomere length in Parkinson's disease: A meta-analysis.
Forero DA; González-Giraldo Y; López-Quintero C; Castro-Vega LJ; Barreto GE; Perry G
Exp Gerontol; 2016 Mar; 75():53-5. PubMed ID: 26772888
[TBL] [Abstract][Full Text] [Related]
4. Effects of water, sanitation, handwashing, and nutritional interventions on telomere length among children in a cluster-randomized controlled trial in rural Bangladesh.
Lin A; Arnold BF; Mertens AN; Lin J; Benjamin-Chung J; Ali S; Hubbard AE; Stewart CP; Shoab AK; Rahman MZ; Hossen MS; Mutsuddi P; Famida SL; Akther S; Rahman M; Unicomb L; Dhabhar FS; Fernald LCH; Colford JM; Luby SP
Elife; 2017 Oct; 6():. PubMed ID: 28980942
[TBL] [Abstract][Full Text] [Related]
5. Long leukocyte telomere length at diagnosis is a risk factor for dementia progression in idiopathic parkinsonism.
Degerman S; Domellöf M; Landfors M; Linder J; Lundin M; Haraldsson S; Elgh E; Roos G; Forsgren L
PLoS One; 2014; 9(12):e113387. PubMed ID: 25501556
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial biogenesis, telomere length and cellular senescence in Parkinson's disease and Lewy body dementia.
Asghar M; Odeh A; Fattahi AJ; Henriksson AE; Miglar A; Khosousi S; Svenningsson P
Sci Rep; 2022 Oct; 12(1):17578. PubMed ID: 36266468
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal Changes in Mitochondrial DNA Copy Number and Telomere Length in Patients with Parkinson's Disease.
Ortega-Vázquez A; Sánchez-Badajos S; Ramírez-García MÁ; Alvarez-Luquín D; López-López M; Adalid-Peralta LV; Monroy-Jaramillo N
Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895262
[TBL] [Abstract][Full Text] [Related]
8. Telomere Attrition in Chronic Kidney Diseases.
Levstek T; Trebušak Podkrajšek K
Antioxidants (Basel); 2023 Feb; 12(3):. PubMed ID: 36978826
[TBL] [Abstract][Full Text] [Related]
9. Systematic Review of Studies on Telomere Length in Patients with Multiple Sclerosis.
Bühring J; Hecker M; Fitzner B; Zettl UK
Aging Dis; 2021 Aug; 12(5):1272-1286. PubMed ID: 34341708
[TBL] [Abstract][Full Text] [Related]
10. No association between blood telomere length and longitudinally assessed diet or adiposity in a young adult Filipino population.
Bethancourt HJ; Kratz M; Beresford SAA; Hayes MG; Kuzawa CW; Duazo PL; Borja JB; Eisenberg DTA
Eur J Nutr; 2017 Feb; 56(1):295-308. PubMed ID: 26497538
[TBL] [Abstract][Full Text] [Related]
11. Ultralong telomeres shorten with age in nestling great tits but are static in adults and mask attrition of short telomeres.
Atema E; Mulder E; van Noordwijk AJ; Verhulst S
Mol Ecol Resour; 2019 May; 19(3):648-658. PubMed ID: 30672119
[TBL] [Abstract][Full Text] [Related]
12. Telomere Attrition in Neurodegenerative Disorders.
Levstek T; Kozjek E; Dolžan V; Trebušak Podkrajšek K
Front Cell Neurosci; 2020; 14():219. PubMed ID: 32760251
[TBL] [Abstract][Full Text] [Related]
13. Effect of master mixes on the measurement of telomere length by qPCR.
Jiménez KM; Forero DA
Mol Biol Rep; 2018 Aug; 45(4):633-638. PubMed ID: 29623565
[TBL] [Abstract][Full Text] [Related]
14. No evidence for shorter leukocyte telomere length in Parkinson's disease patients.
Eerola J; Kananen L; Manninen K; Hellström O; Tienari PJ; Hovatta I
J Gerontol A Biol Sci Med Sci; 2010 Nov; 65(11):1181-4. PubMed ID: 20639300
[TBL] [Abstract][Full Text] [Related]
15. An in silico investigation into the causes of telomere length heterogeneity and its implications for the Hayflick limit.
Golubev A; Khrustalev S; Butov A
J Theor Biol; 2003 Nov; 225(2):153-70. PubMed ID: 14575650
[TBL] [Abstract][Full Text] [Related]
16. Telomere dynamics across the early life course: Findings from a longitudinal study in children.
Cowell W; Tang D; Yu J; Guo J; Wang S; Baccarelli AA; Perera F; Herbstman JB
Psychoneuroendocrinology; 2021 Jul; 129():105270. PubMed ID: 34020264
[TBL] [Abstract][Full Text] [Related]
17. Correlates of telomere length shortening in peripheral leukocytes of HIV-infected individuals and association with leukoaraiosis.
Minami R; Takahama S; Yamamoto M
PLoS One; 2019; 14(6):e0218996. PubMed ID: 31246986
[TBL] [Abstract][Full Text] [Related]
18. Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease.
Bekaert S; De Meyer T; Rietzschel ER; De Buyzere ML; De Bacquer D; Langlois M; Segers P; Cooman L; Van Damme P; Cassiman P; Van Criekinge W; Verdonck P; De Backer GG; Gillebert TC; Van Oostveldt P;
Aging Cell; 2007 Oct; 6(5):639-47. PubMed ID: 17874998
[TBL] [Abstract][Full Text] [Related]
19. The Relationship between Telomere Length and Nucleoplasmic Bridges and Severity of Disease in Prostate Cancer Patients.
Dhillon VS; Deo P; Fenech M
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444460
[TBL] [Abstract][Full Text] [Related]
20. No evidence of substantia nigra telomere shortening in Parkinson's disease.
Hudson G; Faini D; Stutt A; Eccles M; Robinson L; Burn DJ; Chinnery PF
Neurobiol Aging; 2011 Nov; 32(11):2107.e3-5. PubMed ID: 21794951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
